Article
Auranofin Inhibits Hepatitis E Virus Replication Via Reactive Oxygen Species
2025-05-02
Abstract excerpt
Hepatitis E virus (HEV) causes roughly 20 million yearly global infections, and is associated with chronic hepatitis, neurological sequelae and pregnancy-related adverse outcomes that require antiviral therapeutic intervention. While there are currently no approved HEV-specific therapeutics, ribavirin and pegylated interferon, prescribed off-label, are the current standard of care. However, ribavirin resistance an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d91f81e6-f6e1-57c8-856b-2aac2123f00d
- DOI
- 10.1101/2025.05.02.651833
